The Impact of Mood Disorders and Their Treatment on the Pregnant Woman, the Fetus, and the Infant

被引：10

作者：

Kloos, Angelica L. ^{[1
]}

Dubin-Rhodin, Abigail ^{[2
]}

Sackett, Jillan Cantor ^{[3
]}

Dixon, Thomas A. ^{[4
]}

Weller, Ronald A. ^{[5
]}

Weller, Elizabeth B. ^{[6
]}

机构：

[1] Childrens Natl Med Ctr, Dept Child & Adolescent Psychiat, Washington, DC 20010 USA

[2] Columbia Univ, New York, NY 10027 USA

[3] Thomas Jefferson Univ Hosp, Dept Psychiat, Philadelphia, PA 19107 USA

[4] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat, Philadelphia, PA 19104 USA

[5] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA

[6] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

来源：

CURRENT PSYCHIATRY REPORTS | 2010年 / 12卷 / 02期

关键词：

Pregnancy; Mood disorder; Depression; Bipolar disorder; Treatment; SEROTONIN REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; BIPOLAR DISORDER; PSYCHOTROPIC MEDICATION; NEWER ANTIDEPRESSANTS; CLINICAL-TRIAL; DEPRESSION; WOMEN; SAFETY; PREVENTION;

D O I：

10.1007/s11920-010-0098-6

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Treatment of mood disorders in pregnant or nursing women can carry significant risks for the mother and the developing infant. For patients and physicians, it may be difficult to obtain current information to make the proper decisions regarding pharmacologic and alternative treatments. Thus, this paper discusses the risks and benefits of pharmacologic treatment and the risks of not treating depression and bipolar disorder in the pregnant woman. The safety of treatment options is reviewed. Alternative treatment options are also discussed.

引用

页码：96 / 103

页数：8

共 49 条

[1]

ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P1601

[2]

ACOG Committee on Practice Bulletins--Obstetrics, 2008, Obstet Gynecol, V111, P1001, DOI 10.1097/AOG.0b013e31816fd910

[3] ECT in Pregnancy: A Review of the Literature From 1941 to 2007 [J].

Anderson, Eric L. ;

Reti, Irving M. .

PSYCHOSOMATIC MEDICINE, 2009, 71 (02) :235-242

[4] Brief antenatal cognitive behaviour therapy group intervention for the-prevention of postnatal depression and anxiety: A randomised controlled trial [J].

Austin, M. -P. ;

Frilingos, M. ;

Lumley, J. ;

Hadzi-Pavlovic, D. ;

Roncolato, W. ;

Acland, S. ;

Saint, K. ;

Segal, N. ;

Parker, G. .

JOURNAL OF AFFECTIVE DISORDERS, 2008, 105 (1-3) :35-44

[5] Antenatal cognitive-behavioral therapy for prevention of postpartum depression: A pilot study [J].

Cho, Hyun Ju ;

Kwon, Jung Hye ;

Lee, Jeong Jae .

YONSEI MEDICAL JOURNAL, 2008, 49 (04) :553-562

[6] Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment [J].

Cohen, LS ;

Altshuler, LL ;

Harlow, BL ;

Nonacs, R ;

Newport, DJ ;

Viguera, AC ;

Suri, R ;

Burt, VK ;

Hendrick, V ;

Reminick, AM ;

Loughead, A ;

Vitonis, AF ;

Stowe, ZN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :499-507

[7] Exercise and depression: A review of reviews [J].

Daley, Amanda .

JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 2008, 15 (02) :140-147

[8] Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy [J].

Davis, Robert L. ;

Rubanowice, David ;

McPhillips, Heather ;

Raebel, Marsha A. ;

Andrade, Susan E. ;

Smith, David ;

Yood, Marianne Ulcickas ;

Platt, Richard .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) :1086-1094

[9] The Safety of Medications for the Treatment of Bipolar Disorder During Pregnancy and the Puerperium [J].

Dodd, Seetal ;

Berk, Michael .

CURRENT DRUG SAFETY, 2006, 1 (01) :25-33

[10] Treating mood disorders during pregnancy - Safety considerations [J].

Eberhard-Gran, M ;

Eskild, A ;

Opjordsmoen, S .

DRUG SAFETY, 2005, 28 (08) :695-706

← 1 2 3 4 5 →